Peer support for discharge from inpatient mental health care versus care as usual in England (ENRICH): a parallel, two-group, individually randomised controlled trial.
Journal
The lancet. Psychiatry
ISSN: 2215-0374
Titre abrégé: Lancet Psychiatry
Pays: England
ID NLM: 101638123
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
05
08
2021
revised:
28
09
2021
accepted:
30
09
2021
entrez:
23
1
2022
pubmed:
24
1
2022
medline:
3
2
2022
Statut:
ppublish
Résumé
High numbers of patients discharged from psychiatric hospital care are readmitted within a year. Peer support for discharge has been suggested as an approach to reducing readmission post-discharge. Implementation has been called for in policy, however, evidence of effectiveness from large rigorous trials is missing. We aimed to establish whether peer support for discharge reduces readmissions in the year post-discharge. We report a parallel, two-group, individually randomised, controlled superiority trial, with trial personnel masked to allocation. Patients were adult psychiatric inpatients (age ≥18 years) with at least one previous admission in the preceding 2 years, excluding those who had a diagnosis of any organic mental disorder, or a primary diagnosis of learning disability, an eating disorder, or drug or alcohol dependency, recruited from seven state-funded mental health services in England. Patients were randomly assigned (1:1) to the intervention (peer support plus care as usual) or control (care as usual) groups by an in-house, online randomisation service, stratified by site and diagnostic group (psychotic disorders, personality disorders, and other eligible non-psychotic disorders) with randomly permuted blocks of randomly varying length to conceal the allocation sequence and achieve the allocation ratio. The peer support group received manual-based, one-to-one peer support, focused on building individual strengths and engaging with activities in the community, beginning during the index admission and continuing for 4 months after discharge, plus care as usual. Care as usual consisted of follow-up by community mental health services within 7 days of discharge. The primary outcome was psychiatric readmission 12 months after discharge (number of patients readmitted at least once), analysed on an intention-to-treat basis. All patients were included in a safety analysis, excluding those who withdrew consent for use of their data. The trial is registered with the ISRCTN registry, ISRCTN10043328. The trial was complete at the time of reporting. Between Dec 1, 2016, and Feb 8, 2019, 590 patients were recruited and randomly assigned, with 294 allocated to peer support (287 included in the analysis after withdrawals and loss to follow-up), and 296 to care as usual (291 in the analysis). Mean age was 39·7 years (SD 13·7; range 18-75). 306 patients were women, 267 were men, three were transgender, and two preferred not to say. 353 patients were White, 94 were Black, African, Caribbean, or Black British, 68 were Asian or Asian British, 48 were of mixed or multiple ethnic groups, and 13 were of other ethnic groups. In the peer support group, 136 (47%) of 287 patients were readmitted at least once within 12 months of discharge. 146 (50%) of 291 were readmitted in the care as usual group. The adjusted risk ratio of readmission was 0·97 (95% CI 0·82-1·14; p=0·68), and the adjusted odds ratio for readmission was 0·93 (95% CI 0·66-1·30; p=0·68). The unadjusted risk difference was 0·03 (95% CI -0·11 to 0·05; p=0·51) in favour of the peer support group. Serious adverse events were infrequent (67 events) and similar between groups (34 in the peer support group, 33 in the care as usual group). Threat to life (self-harm) was the most common serious adverse event (35 [52%] of 67 serious adverse events). 391 other adverse events were reported, with self-harm (not life threatening) the most common (189 [48%] of 391). One-to-one peer support for discharge from inpatient psychiatric care, plus care as usual, was not superior to care as usual alone in the 12 months after discharge. This definitive, high-quality trial addresses uncertainty in the evidence base and suggests that peer support should not be implemented to reduce readmission post-discharge for patients at risk of readmission. Further research needs to be done to improve engagement with peer support in high-need groups, and to explore differential effects of peer support for people from different ethnic communities. UK National Institute for Health Research.
Sections du résumé
BACKGROUND
High numbers of patients discharged from psychiatric hospital care are readmitted within a year. Peer support for discharge has been suggested as an approach to reducing readmission post-discharge. Implementation has been called for in policy, however, evidence of effectiveness from large rigorous trials is missing. We aimed to establish whether peer support for discharge reduces readmissions in the year post-discharge.
METHODS
We report a parallel, two-group, individually randomised, controlled superiority trial, with trial personnel masked to allocation. Patients were adult psychiatric inpatients (age ≥18 years) with at least one previous admission in the preceding 2 years, excluding those who had a diagnosis of any organic mental disorder, or a primary diagnosis of learning disability, an eating disorder, or drug or alcohol dependency, recruited from seven state-funded mental health services in England. Patients were randomly assigned (1:1) to the intervention (peer support plus care as usual) or control (care as usual) groups by an in-house, online randomisation service, stratified by site and diagnostic group (psychotic disorders, personality disorders, and other eligible non-psychotic disorders) with randomly permuted blocks of randomly varying length to conceal the allocation sequence and achieve the allocation ratio. The peer support group received manual-based, one-to-one peer support, focused on building individual strengths and engaging with activities in the community, beginning during the index admission and continuing for 4 months after discharge, plus care as usual. Care as usual consisted of follow-up by community mental health services within 7 days of discharge. The primary outcome was psychiatric readmission 12 months after discharge (number of patients readmitted at least once), analysed on an intention-to-treat basis. All patients were included in a safety analysis, excluding those who withdrew consent for use of their data. The trial is registered with the ISRCTN registry, ISRCTN10043328. The trial was complete at the time of reporting.
FINDINGS
Between Dec 1, 2016, and Feb 8, 2019, 590 patients were recruited and randomly assigned, with 294 allocated to peer support (287 included in the analysis after withdrawals and loss to follow-up), and 296 to care as usual (291 in the analysis). Mean age was 39·7 years (SD 13·7; range 18-75). 306 patients were women, 267 were men, three were transgender, and two preferred not to say. 353 patients were White, 94 were Black, African, Caribbean, or Black British, 68 were Asian or Asian British, 48 were of mixed or multiple ethnic groups, and 13 were of other ethnic groups. In the peer support group, 136 (47%) of 287 patients were readmitted at least once within 12 months of discharge. 146 (50%) of 291 were readmitted in the care as usual group. The adjusted risk ratio of readmission was 0·97 (95% CI 0·82-1·14; p=0·68), and the adjusted odds ratio for readmission was 0·93 (95% CI 0·66-1·30; p=0·68). The unadjusted risk difference was 0·03 (95% CI -0·11 to 0·05; p=0·51) in favour of the peer support group. Serious adverse events were infrequent (67 events) and similar between groups (34 in the peer support group, 33 in the care as usual group). Threat to life (self-harm) was the most common serious adverse event (35 [52%] of 67 serious adverse events). 391 other adverse events were reported, with self-harm (not life threatening) the most common (189 [48%] of 391).
INTERPRETATION
One-to-one peer support for discharge from inpatient psychiatric care, plus care as usual, was not superior to care as usual alone in the 12 months after discharge. This definitive, high-quality trial addresses uncertainty in the evidence base and suggests that peer support should not be implemented to reduce readmission post-discharge for patients at risk of readmission. Further research needs to be done to improve engagement with peer support in high-need groups, and to explore differential effects of peer support for people from different ethnic communities.
FUNDING
UK National Institute for Health Research.
Identifiants
pubmed: 35065722
pii: S2215-0366(21)00398-9
doi: 10.1016/S2215-0366(21)00398-9
pmc: PMC8776565
pii:
doi:
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
125-136Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of interests We declare no competing interests.
Références
BMC Psychiatry. 2020 Nov 11;20(1):534
pubmed: 33176729
Health Technol Assess. 2015 Nov;19(93):1-115, v-vi
pubmed: 26560448
Epidemiol Psychiatr Sci. 2018 Dec 18;29:e10
pubmed: 30560756
Epidemiol Psychiatr Sci. 2016 Apr;25(2):181-93
pubmed: 25703270
Int J Soc Psychiatry. 1999 Spring;45(1):7-12
pubmed: 10443245
J Ment Health Adm. 1995 Spring;22(2):135-46
pubmed: 10142127
Acta Psychiatr Scand. 2008 Jul;118(1):57-63
pubmed: 18582348
Psychiatr Rehabil J. 2016 Sep;39(3):248-255
pubmed: 27618461
BMC Med. 2018 Dec 12;16(1):223
pubmed: 30537961
BMC Psychiatry. 2014 Feb 14;14:39
pubmed: 24528545
Epidemiol Psychiatr Sci. 2015 Oct;24(5):435-45
pubmed: 24992284
BMC Psychiatry. 2020 Aug 8;20(1):401
pubmed: 32770970
Medicine (Baltimore). 2020 Mar;99(10):e19192
pubmed: 32150057
JAMA Psychiatry. 2017 Jul 1;74(7):694-702
pubmed: 28564699
Lancet. 2018 Aug 4;392(10145):409-418
pubmed: 30102174
J Ment Health. 2019 Aug;28(4):341-344
pubmed: 31070066
Compr Psychiatry. 2016 Apr;66:59-66
pubmed: 26995237
J Adv Nurs. 1992 Oct;17(10):1251-9
pubmed: 1430629
BMJ. 2013 Oct 07;347:f5847
pubmed: 24100934
Lancet Psychiatry. 2019 Dec;6(12):1039-1053
pubmed: 31777340
Cochrane Database Syst Rev. 2013 Mar 28;(3):CD004807
pubmed: 23543537
Gen Hosp Psychiatry. 2016 Mar-Apr;39:53-8
pubmed: 26804775
BMC Psychiatry. 2014 Feb 05;14:30
pubmed: 24495599
J Psychiatr Ment Health Nurs. 2004 Feb;11(1):82-8
pubmed: 14723643
BMC Psychiatry. 2017 Jun 24;17(1):227
pubmed: 28646857
J Psychiatr Ment Health Nurs. 2005 Oct;12(5):556-64
pubmed: 16164506
Br J Psychiatry. 2013 Mar;202(3):187-94
pubmed: 23457182
Stat Med. 2016 May 10;35(10):1616-36
pubmed: 26670388
N Z Med J. 2011 Jun 10;124(1336):30-8
pubmed: 21946742
Psychiatr Serv. 2018 Sep 1;69(9):961-977
pubmed: 29962310
Br J Psychiatry. 2018 Oct;213(4):574-578
pubmed: 30131082